Does the Human Gut Microbiome Serve as a Novel Personalized Therapeutic Target for Coronary Atherosclerosis?
Clinical trial NCT03009565 · UNKNOWN
Trial details
- NCT number
- NCT03009565
- Sponsor
- Rabin Medical Center
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2017-01-01
- Primary completion
- 2018-01-01
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.